-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Initiates Coverage On Veradermics with Buy Rating, Announces Price Target of $170

Benzinga·07/15/2026 10:27:18
Listen to the news
B. Riley Securities analyst Mayank Mamtani initiates coverage on Veradermics (NYSE:MANE) with a Buy rating and announces Price Target of $170.